Clinical Trial Update: Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Lung-MAP is a master screening protocol for patients with previously treated non-small cell lung cancer, currently in Phase 2 and Phase 3 and recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Previously Treated Non-Small Cell Lung Cancer | Phase 2, Phase 3 | Status: RECRUITING